CoapTech, a medical technology company advancing ultrasound‑guided solutions for enteral access, today announced that its Board of Directors has appointed Brad Kreger as Chief Executive Officer. Co‑Founder and Chief Executive Officer, Howard Carolan, is stepping down from the role of CEO and will remain as an advisor to support a smooth transition.
Prior to joining CoapTech, Kreger served as the CEO of Velo3D, where he led the organization through a significant retooling of its go-to-market strategy and commercialization of high demand and rapidly growing service offerings. Prior to that, he held the position of Senior Vice President, Global Operations at Fluidigm Corporation, and various senior leadership roles at Thermo Fisher Scientific and Affymetrix Inc.
“We are excited to welcome Brad as our next CEO. Brad’s background in medical device manufacturing, and his track record of scaling organizations makes him uniquely suited to accelerate CoapTech’s growth and lead the company to its next stage.” said Bill Walker Ph.D., Chairman of the Board at CoapTech. “On behalf of the Board, I want to extend our deepest gratitude to Howard for his vision, grit, and unwavering commitment to patients. Guiding CoapTech from a founding concept to a commercial organization that improves outcomes for patients is a major achievement.”
“I am honored to continue building from the incredible foundation that Howard has created,” said Kreger. “I look forward to working with our amazing team to expand access to our percutaneous ultrasound gastrostomy technology, accelerate adoption across care settings, and deepen its impact on patients and healthcare providers.”
